Tevogen Bio Finalizes Agreement for Company’s Own Cell Therapy Production Facility
The agreement would facilitate providing Tevogen Bio with in-house cell therapy production capabilitiesFormalized agreement aligns with previously announced topline forecasts WARREN, N.J., April 17, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio…
CORRECTION NOTICE: Stride Announces Date for Third Quarter Fiscal Year 2025 Earnings Call
RESTON, VA, April 16, 2025 (GLOBE NEWSWIRE) -- Stride Inc. (NYSE: LRN) announced today it plans to discuss its third quarter fiscal year 2025 financial results during a conference call…
SPINEWAY : Chiffre d’affaires du 1er trimestre 2025 de 2,8 M€
Communiqué de presse Ecully, le 16 avril 2025 – 19h SPINEWAY Chiffre d’affaires du 1er trimestre 2025 de 2,8 M€ En milliers d’euros20252024Variation en %CA 1er trimestre2 8283 070- 8%…
Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 15 04 2025]
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a)…
Spineway : First-quarter 2025 revenue of €2.8 million
Press release Ecully, April 16, 2025 – 7.00 p.m. SPINEWAY First-quarter 2025 revenue of €2.8 million In thousands of euros20252024Change as a %Q1 revenue2,8283,070-8% Unaudited consolidated data Spineway, a specialist…
Montero Announces Share Consolidation and C$15M Return of Capital
TORONTO, April 16, 2025 (GLOBE NEWSWIRE) -- Montero Mining and Exploration Ltd. (TSX-V: MON) (OTCPK: MXTRF) (“Montero” or the “Company”) announces that it has finalized its planned uses of the…
Mx2 Mining Completes Transaction with Aya Gold & Silver
TORONTO, April 16, 2025 (GLOBE NEWSWIRE) -- Mx2 Mining Inc. (“Mx2” or the “Company”) is pleased to announce the completion of the previously announced transaction with Aya Gold & Silver…
U.S. Energy Corp. Announces Acreage Acquisition and CCUS Development Update
HOUSTON, April 16, 2025 (GLOBE NEWSWIRE) -- U.S. Energy Corporation (NASDAQ: USEG, “U.S. Energy” or the “Company”) today announced the closing of a strategic acquisition (the “Acquisition”) from a privately…
Basilea shareholders approve all proposals of the board of directors at the annual general meeting
Allschwil, Switzerland, April 16, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported that…
Basilea-Aktionäre genehmigen an der Generalversammlung alle Anträge des Verwaltungsrats
Allschwil, 16. April 2025 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel, Patienten zu helfen, die an schweren Infektionen durch Bakterien oder…